Change of Name

Recorded: 2022-02-14 Pages: 3

Assignor

NEUROPHAGE PHARMACEUTICALS, INC.

Executed: 2016-07-21

Assignee

PROCLARA BIOSCIENCES, INC.

125 CAMBRIDGEPARK DR #301, CAMBRIDGE, MASSACHUSETTS, 02140

Covered Property (1)

Polypeptides Comprising a Modified Bacteriophage G3P Amino Acid Sequence with Reduced Immunogenicity

Application: 61/828,004 →

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.